Zai Lab Ltd 4

CFO Chen Yajing sold 260 Zai Lab Ltd ADSs at $27.00 each on August 19, 2026 under a Rule 10b5-1 trading plan.

On August 19, 2026, Zai Lab Ltd Chief Financial Officer Chen Yajing sold 260 American Depositary Shares (ADSs) of Zai Lab Ltd at a price of $27.00 per ADS pursuant to a pre-established Rule 10b5-1 trading plan, for total proceeds of approximately $7,020. Following this sale, the reporting person beneficially owned 35,635 ADSs, each representing ten ordinary shares of the issuer, with the filing noting that the ADSs and ordinary shares are fully fungible. The transaction appears to be a relatively small, pre-planned discretionary sale rather than a significant directional change in insider ownership.

Filing Facts

CIK

1704292

Ticker

ZLAB

Form

4

Source Type

fda

Accession

0000905148-26-003867

Alert Tier

5